Cite
METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer's disease through aberrant cell cycle events.
MLA
Zhao, Fanpeng, et al. “METTL3-Dependent RNA M6A Dysregulation Contributes to Neurodegeneration in Alzheimer’s Disease through Aberrant Cell Cycle Events.” Molecular Neurodegeneration, vol. 16, no. 1, Sept. 2021, pp. 1–25. EBSCOhost, https://doi.org/10.1186/s13024-021-00484-x.
APA
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., O’Donnell, J. M., Tang, B., & Zhu, X. (2021). METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events. Molecular Neurodegeneration, 16(1), 1–25. https://doi.org/10.1186/s13024-021-00484-x
Chicago
Zhao, Fanpeng, Ying Xu, Shichao Gao, Lixia Qin, Quillan Austria, Sandra L. Siedlak, Kinga Pajdzik, et al. 2021. “METTL3-Dependent RNA M6A Dysregulation Contributes to Neurodegeneration in Alzheimer’s Disease through Aberrant Cell Cycle Events.” Molecular Neurodegeneration 16 (1): 1–25. doi:10.1186/s13024-021-00484-x.